Largest genome sequencing project launched in UK
The UK Biobank, the world’s largest genetics project, will sequence 500,000 genetic samples, which will be available to researchers everywhere.
List view / Grid view
The UK Biobank, the world’s largest genetics project, will sequence 500,000 genetic samples, which will be available to researchers everywhere.
Researchers have discovered an enzyme that is pivotal in deciding whether cells survive or die in inflammatory diseases, so provides a drug target.
A study on how Polycombs regulate cellular identity could lead to alternative treatments for patients with drug-resistant cancer.
Researchers discover that a non-coding region of the genome originates a key molecule for the proliferation of cancerous tumours.
A study has used CRISPR-Cas9 to treat obesity and type 2 diabetes symptoms in mice, highlighting the potential use in humans.
Scientists reveal the atomic structure and regulative mechanism of the metabolic enzyme transhydrogenase.
A protein discovery could lead to a new and highly potent immune-therapeutic drug for the eradication of cancers using natural killer cells.
Using new technology researchers have shown that sick mitochondria pollute the cells they are supposed to be supplying with power.
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
The structure of a key receptor involved in tumour metastasis has been imaged in a study, providing opportunities to develop cancer treatments.
A new study has identified possible regulators that determine differences in cancer tumours between genders.
A new technique called ‘ubiquitin clipping’ has been created which could aid proteomics research and the development of new drugs for ubiquitination.
A study has found that signals from interferons can be blocked, allowing the immune system to attack tumours which provides a potential target.
It has been discovered that Polo-like kinase (PLK1) guards against severe DNA damage and could help target fast-growing cancer cells.
Researchers have identified the process behind cancer cell energy production, providing a drug target for treatments to inhibit growth.